Ozole D 10mg/20mg Capsule is a combination pharmaceutical formulation containing Domperidone 10mg and Omeprazole 20mg, indicated for the management of gastroesophageal reflux disease (GERD), dyspepsia, and related gastrointestinal disorders. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric motility and accelerates gastric emptying, thereby alleviating symptoms such as nausea, vomiting, and bloating. Omeprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in gastric parietal cells, promoting mucosal healing and symptom relief in acid-related conditions. The synergistic action of these agents provides effective symptomatic control by reducing acid reflux and enhancing gastrointestinal motility. Ozole D is typically administered orally once daily before meals, with dosage adjustments based on clinical response and patient tolerance. Caution is advised in patients with hepatic impairment, and it is contraindicated in individuals with known hypersensitivity to either component. Potential side effects may include headache, dry mouth, abdominal discomfort, and, rarely, extrapyramidal symptoms due to Domperidone. This combination therapy should be used under medical supervision, ensuring appropriate evaluation of benefits and risks in patients with gastrointestinal complaints.